Reference
1. Tran LT, Carullo PC, Banh DPT, Vitu C, Davis PJ. Pediatric Liver Transplantation: Then and Now. J Cardiothorac Vasc Anesth. 2020;34(8):2028-35.
2. Jothimani D, Venugopal R, Vij M, Rela M. Post liver transplant recurrent and de novo viral infections. Best Pract Res Clin Gastroenterol. 2020;46-47:101689.
3. Baker A, Frauca Remacha E, Torres Canizales J, Bravo-Gallego LY, Fitzpatrick E, Alonso Melgar A, et al. Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group Survey. Children (Basel). 2021;8(8).
4. Fishman JA. Infection in Organ Transplantation. Am J Transplant. 2017;17(4):856-79.
5. Llaurador G, McLaughlin L, Wistinghausen B. Management of post-transplant lymphoproliferative disorders. Curr Opin Pediatr. 2017;29(1):34-40.
6. DeStefano CB, Desai SH, Shenoy AG, Catlett JP. Management of post-transplant lymphoproliferative disorders. Br J Haematol. 2018;182(3):330-43.
7. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4(2):222-30.
8. Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015;390(Pt 1):211-40.
9. Grimm KE, O’Malley DP. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues. Ann Diagn Pathol. 2019;38:6-10.
10. Aguilera N, Gru AA. Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types. Semin Diagn Pathol. 2018;35(4):236-46.
11. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90.
12. Montes de Jesus FM, Glaudemans A, Tissing WJ, Dierckx R, Rosati S, Diepstra A, et al. (18)F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders. J Nucl Med. 2020;61(9):1307-13.
13. Montes de Jesus F, Vergote V, Noordzij W, Dierickx D, Dierckx R, Diepstra A, et al. Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [(18)F]FDG PET/CT. J Clin Med. 2021;10(2).
14. Hwang CS, Macconmara M, Desai DM. Pediatric Abdominal Organ Transplantation. Surg Clin North Am. 2019;99(1):73-85.
15. Qin T, Gu XQ, Jeong SS, Song YY, Liu JC, Zheng JX, et al. Impact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: A single-center experience. Hepatobiliary Pancreat Dis Int. 2020;19(1):3-11.
16. L’Huillier AG, Dipchand AI, Ng VL, Hebert D, Avitzur Y, Solomon M, et al. Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients. Transplantation. 2019;103(11):e369-e74.
17. Seo E, Kim J, Oh SH, Kim KM, Kim DY, Lee J. Epstein-Barr viral load monitoring for diagnosing post-transplant lymphoproliferative disorder in pediatric liver transplant recipients. Pediatr Transplant. 2020;24(4):e13666.
18. Dharnidharka VR, Lamb KE, Gregg JA, Meier-Kriesche HU. Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant. 2012;12(4):976-83.
19. Song H, Guja KE, Iagaru A. (18)F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD). Semin Nucl Med. 2021;51(4):392-403.
20. Vali R, Punnett A, Bajno L, Moineddin R, Shammas A. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Pediatr Transplant. 2015;19(8):932-9.
21. Montes de Jesus FM, Kwee TC, Kahle XU, Nijland M, van Meerten T, Huls G, et al. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield. Eur J Nucl Med Mol Imaging. 2020;47(3):529-36.
22. Montes de Jesus FM, Kwee TC, Nijland M, Kahle XU, Huls G, Dierckx R, et al. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018;132:27-38.
23. Ballova V, Muoio B, Albano D, Bertagna F, Canziani L, Ghielmini M, et al. Diagnostic Performance of (18)F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis. Diagnostics (Basel). 2020;10(2).
24. Treglia G, Ceriani L. (18)F-FDG PET/CT in patients with post-transplant lymphoproliferative disorders: so far so good. Eur J Nucl Med Mol Imaging. 2020;47(3):523-4.
25. Xu YF, Yang JG. Roles of F-18-Fluoro-2-Deoxy-Glucose PET/Computed Tomography Scans in the Management of Post-Transplant Lymphoproliferative Disease in Pediatric Patient. PET Clin. 2020;15(3):309-19.
26. Okamoto T, Okajima H, Uebayashi EY, Ogawa E, Yamada Y, Umeda K, et al. Management of Epstein-Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation. J Clin Med. 2022;11(8).
27. von Falck C, Maecker B, Schirg E, Boerner AR, Knapp WH, Klein C, et al. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol. 2007;63(3):427-35.
28. Sidell D, Venick RS, Shapiro NL. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients. Laryngoscope. 2014;124(5):1236-41.
29. Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, et al. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. 2016;101(7):803-11.
30. Dierickx D, Tousseyn T, Requile A, Verscuren R, Sagaert X, Morscio J, et al. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder. Haematologica. 2013;98(5):771-5.
31. San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, et al. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:109-18.
32. Marques HH, Shikanai-Yasuda MA, dAzevedo LS, Caiaffa-Filho HH, Pierrotti LC, Aquino MZ, et al. Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients. Rev Soc Bras Med Trop. 2014;47(5):543-6.